Cleared Traditional

K240503 - Sonata Transcervical Fibroid Ablation System 2.2
(FDA 510(k) Clearance)

Jul 2024
Decision
147d
Days
Class 2
Risk

K240503 is an FDA 510(k) clearance for the Sonata Transcervical Fibroid Ablation System 2.2. This device is classified as a Coagulator-cutter, Endoscopic, Unipolar (and Accessories) (Class II - Special Controls, product code KNF).

Submitted by Gynesonics, Inc. (Redwood City, US). The FDA issued a Cleared decision on July 17, 2024, 147 days after receiving the submission on February 21, 2024.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.4160.

Submission Details

510(k) Number K240503 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 21, 2024
Decision Date July 17, 2024
Days to Decision 147 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code KNF — Coagulator-cutter, Endoscopic, Unipolar (and Accessories)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 884.4160

Similar Devices — KNF Coagulator-cutter, Endoscopic, Unipolar (and Accessories)

All 43
Sonata Transcervical Fibroid Ablation System 2.2
K250705 · Gynesonics, Inc. · Apr 2025
Sonata Transcervical Fibroid Ablation System 2.2 (SONATA2-220)
K233848 · Gynesonics, Inc. · Dec 2023
Sonata Transcervical Fibroid Ablation System 2.2
K222304 · Gynesonics, Inc. · Nov 2022
Sonata Transcervical Fibroid Ablation System 2.2
K211535 · Gynesonics, Inc. · Jun 2021
Sonata? Sonography-Guided Transcervical Fibroid Ablation System 2.1
K193516 · Gynesonics, Inc. · May 2020
Sonata Sonography-Guided Transcervical Fibroid Ablation System
K173703 · Gynesonics, Inc. · Aug 2018